190 related articles for article (PubMed ID: 32798728)
1. Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease.
Pascua-Maestro R; Corraliza-Gomez M; Fadrique-Rojo C; Ledesma MD; Schuchman EH; Sanchez D; Ganfornina MD
Neurobiol Dis; 2020 Oct; 144():105046. PubMed ID: 32798728
[TBL] [Abstract][Full Text] [Related]
2. Protecting cells by protecting their vulnerable lysosomes: Identification of a new mechanism for preserving lysosomal functional integrity upon oxidative stress.
Pascua-Maestro R; Diez-Hermano S; Lillo C; Ganfornina MD; Sanchez D
PLoS Genet; 2017 Feb; 13(2):e1006603. PubMed ID: 28182653
[TBL] [Abstract][Full Text] [Related]
3. Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
Gabandé-Rodríguez E; Pérez-Cañamás A; Soto-Huelin B; Mitroi DN; Sánchez-Redondo S; Martínez-Sáez E; Venero C; Peinado H; Ledesma MD
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30530526
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
[TBL] [Abstract][Full Text] [Related]
5. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
Gabandé-Rodríguez E; Boya P; Labrador V; Dotti CG; Ledesma MD
Cell Death Differ; 2014 Jun; 21(6):864-75. PubMed ID: 24488099
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
[TBL] [Abstract][Full Text] [Related]
8. Myelin extracellular leaflet compaction requires apolipoprotein D membrane management to optimize lysosomal-dependent recycling and glycocalyx removal.
García-Mateo N; Pascua-Maestro R; Pérez-Castellanos A; Lillo C; Sanchez D; Ganfornina MD
Glia; 2018 Mar; 66(3):670-687. PubMed ID: 29222871
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems.
Bajo-Grañeras R; Ganfornina MD; Martín-Tejedor E; Sanchez D
Glia; 2011 Oct; 59(10):1551-66. PubMed ID: 21688324
[TBL] [Abstract][Full Text] [Related]
10. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.
Carsana EV; Lunghi G; Prioni S; Mauri L; Loberto N; Prinetti A; Zucca FA; Bassi R; Sonnino S; Chiricozzi E; Duga S; Straniero L; Asselta R; Soldà G; Samarani M; Aureli M
J Mol Neurosci; 2022 Jul; 72(7):1482-1499. PubMed ID: 35727525
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
[TBL] [Abstract][Full Text] [Related]
12. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
13. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress.
Ganfornina MD; Do Carmo S; Lora JM; Torres-Schumann S; Vogel M; Allhorn M; González C; Bastiani MJ; Rassart E; Sanchez D
Aging Cell; 2008 Aug; 7(4):506-15. PubMed ID: 18419796
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion.
Soto-Huelin B; Babiy B; Pastor O; Díaz-García M; Toledano-Zaragoza A; Frutos MD; Espín JC; Tomás-Barberán FA; Busto R; Ledesma MD
Neurobiol Dis; 2023 Jun; 182():106141. PubMed ID: 37121555
[TBL] [Abstract][Full Text] [Related]
17. Aging without Apolipoprotein D: Molecular and cellular modifications in the hippocampus and cortex.
Sanchez D; Bajo-Grañeras R; Del Caño-Espinel M; Garcia-Centeno R; Garcia-Mateo N; Pascua-Maestro R; Ganfornina MD
Exp Gerontol; 2015 Jul; 67():19-47. PubMed ID: 25868396
[TBL] [Abstract][Full Text] [Related]
18. c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease.
Marín T; Dulcey AE; Campos F; de la Fuente C; Acuña M; Castro J; Pinto C; Yañez MJ; Cortez C; McGrath DW; Sáez PJ; Gorshkov K; Zheng W; Southall N; Carmo-Fonseca M; Marugán J; Alvarez AR; Zanlungo S
Front Cell Dev Biol; 2022; 10():844297. PubMed ID: 35399514
[TBL] [Abstract][Full Text] [Related]
19. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function.
Marathe S; Miranda SR; Devlin C; Johns A; Kuriakose G; Williams KJ; Schuchman EH; Tabas I
Hum Mol Genet; 2000 Aug; 9(13):1967-76. PubMed ID: 10942425
[TBL] [Abstract][Full Text] [Related]
20. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]